UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

SCHEDULE 14A

(Rule 14a-101)

 

INFORMATION REQUIRED IN PROXY STATEMENT

SCHEDULE 14A INFORMATION

 

Proxy Statement Pursuant to Section 14(a) of the Securities

Exchange Act of 1934 (Amendment No.)

 

Filed by the Registrant ☒

 

Filed by a Party other than the Registrant ☐

 

Check the appropriate box:

 

Preliminary Proxy Statement
   
Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
   
Definitive Proxy Statement
   
Definitive Additional Materials
   
Soliciting Material Pursuant to § 240.14a-12

 

HANCOCK JAFFE LABORATORIES, INC.

(Name of Registrant as Specified in Its Charter)

 

 

(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)

 

Payment of Filing Fee (Check the appropriate box):

 

No fee required.
   
Fee computed on table below per Exchange Act Rules 14a-6(i) (1) and 0-11.
   
(1) Title of each class of securities to which transaction applies:
   
(2) Aggregate number of securities to which transaction applies:
   
(3) Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
   
(4) Proposed maximum aggregate value of transaction:
   
(5) Total fee paid:
   
Fee paid previously with preliminary materials:
   
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
   
(1) Amount previously paid:
   
(2) Form, Schedule or Registration Statement No.:
   
(3) Filing Party:
   
(4) Date Filed:

 

 

 

 
 

 

Additional Information Regarding Hancock Jaffe Laboratories, Inc.’s Annual Meeting of Stockholders to be Held on September 15, 2020

 

Hancock Jaffe Laboratories, Inc. mailed to its stockholders the following letter along with an updated proxy card which replaces the proxy card filed with the company’s proxy statement filed with the Securities and Exchange Commission on August 12, 2020 and furnished to its stockholders in connection with the solicitation of proxies for use at the Annual Meeting of Stockholders to be held on September 15, 2020.

 

Letter to Stockholders

 

Dear Hancock Jaffe Laboratories Stockholder,

 

Enclosed please find a revised proxy card which supersedes the proxy card previously sent to you. There is an additional voting item on this proxy card to match the number of agenda items set forth on the Notice of Meeting in the proxy statement.

 

Please refrain from voting the proxy card that you previously received and utilize the enclosed proxy card instead. If you have already voted the previous proxy card, we ask that you also vote the enclosed card so that your shares will be voted on all six agenda items.

 

There are no changes to the proxy statement you previously received. You may still refer to that statement to make your voting decision.

 

You may also vote your shares on the voting website at www.proxyvote.com.

 

Your vote remains extremely important, and we apologize for any inconvenience to you.

 

 

 

This supplement is being filed with the Securities and Exchange Commission on August 18, 2020 and will be mailed to stockholders on or before August 21, 2020.

 

This supplement should be read in conjunction with Hancock Jaffe Laboratories, Inc.’s proxy statement filed with the Securities and Exchange Commission on August 12, 2020.